For example, it has recently been reported that miR-19a-3p induced sorafenib resistance by inhibiting PTEN and subsequent activation of PI3K/AKT, leading to increased EMT, cell migration, and acquisition of stem cell-like properties in HCC cells, rendering these cells more resistant to sorafenib (119). This evidence concerns the gene AKT1 and hepatocellular carcinoma.